Skip to main content

. 1958 Sep;17(3):326–333. doi: 10.1136/ard.17.3.326

Value of Uricosuric Agents and in Particular of G.28 315 in Gout

G D Kersley ¹, E R Cook ¹, D C J Tovey ¹

PMCID: PMC1007056 PMID: 13583918

326

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

BIDMEAD D. S. A modified technique for determining uric acid in blood and urine. J Clin Pathol. 1951 Aug;4(3):370–373. doi: 10.1136/jcp.4.3.370. [DOI] [PMC free article] [PubMed] [Google Scholar]
BURNS J. J., YU T. F., RITTERBAND A., PEREL J. M., GUTMAN A. B., BRODIE B. B. A potent new uricosuric agent, the sulfoxide metabolite of the phenylbutazone analogue, G-25671. J Pharmacol Exp Ther. 1957 Mar;119(3):418–426. [PubMed] [Google Scholar]
GUTMAN A. B., YU T. F. Current principles of management in gout. Am J Med. 1952 Dec;13(6):744–759. doi: 10.1016/0002-9343(52)90374-4. [DOI] [PubMed] [Google Scholar]
KERSLEY G. D., MANDEL L., BENE E. Gout; observations on the effects of drugs on plasma uric acid and urinary uric acid. Ann Rheum Dis. 1951 Sep;10(3):353–358. doi: 10.1136/ard.10.3.353. [DOI] [PMC free article] [PubMed] [Google Scholar]
OGRYZLO M. A., HARRISON J. Evaluation of uricosuric agents in chronic gout. Ann Rheum Dis. 1957 Dec;16(4):425–437. doi: 10.1136/ard.16.4.425. [DOI] [PMC free article] [PubMed] [Google Scholar]
PASCALE L. R., DUBIN A., HOFFMAN W. S. Therapeutic value of probenecid (benemid) in gout. J Am Med Assoc. 1952 Jul 26;149(13):1188–1194. doi: 10.1001/jama.1952.02930300014004. [DOI] [PubMed] [Google Scholar]
YU T. F., SIROTA J. H., GUTMAN A. B. Effect of phenylbutazone (3,5 dioxo-1,2-diphenyl-4-n-butylpyrazolidine) on renal clearance of urate and other discrete renal functions in gouty subjects. J Clin Invest. 1953 Nov;32(11):1121–1132. doi: 10.1172/JCI102836. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES